User profiles for F. CORONA

Francesco Corona

Aalto University
Verified email at aalto.fi
Cited by 2368

[HTML][HTML] Bacterial multidrug efflux pumps: much more than antibiotic resistance determinants

…, JA Reales-Calderon, F Corona, F Lira… - Microorganisms, 2016 - mdpi.com
Bacterial multidrug efflux pumps are antibiotic resistance determinants present in all
microorganisms. With few exceptions, they are chromosomally encoded and present a conserved …

Data-derived soft-sensors for biological wastewater treatment plants: An overview

H Haimi, M Mulas, F Corona, R Vahala - Environmental modelling & …, 2013 - Elsevier
This paper surveys and discusses the application of data-derived soft-sensing techniques in
biological wastewater treatment plants. Emphasis is given to an extensive overview of the …

[HTML][HTML] Phenotypic resistance to antibiotics

F Corona, JL Martinez - Antibiotics, 2013 - mdpi.com
The development of antibiotic resistance is usually associated with genetic changes, either
to the acquisition of resistance genes, or to mutations in elements relevant for the activity of …

2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American …

…, L Breda, V Chasnyk, R Cimaz, F Corona… - Arthritis & …, 2016 - Wiley Online Library
… De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A. Correlation of serum
… Strippoli R, Caiello I, de Benedetti F. Reaching the threshold: a multilayer pathogenesis of …

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to …

…, M Alessio, R Burgos‐Vargas, F Corona… - … : Official Journal of …, 2004 - Wiley Online Library
Objective To compare the safety and efficacy of parenteral methotrexate (MTX) at an intermediate
dosage (15 mg/m 2 /week) versus a higher dosage (30 mg/m 2 /week) in patients with …

Localized scleroderma in childhood is not just a skin disease

…, N Ruperto, J Harper, G Espada, F Corona… - Arthritis & …, 2005 - Wiley Online Library
Objective Juvenile localized scleroderma is usually considered a disease that is confined to
the skin and subcutaneous tissue. We studied the prevalence and clinical features of …

Extreme learning machines [trends & controversies]

…, A Akusok, A Lendasse, F Corona… - IEEE intelligent …, 2013 - ieeexplore.ieee.org
This special issue includes eight original works that detail the further developments of ELMs
in theories, applications, and hardware implementation. In "Representational Learning with …

Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial

…, J García-Consuegra, L Lepore, G Susic, F Corona… - Jama, 2010 - jamanetwork.com
Context Novel therapies have improved the remission rate in chronic inflammatory disorders
including juvenile idiopathic arthritis (JIA). Therefore, strategies of tapering therapy and …

Long‐term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

…, R Cuttica, M Beltramelli, F Corona… - Arthritis Care & …, 2010 - Wiley Online Library
Longâ•’term outcome and prognostic factors of juvenile dermatomyositis: A multinational,
multicenter study of 490 patients Page 1 Long-Term Outcome and Prognostic Factors of …

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

…, G Sterba, T Avcin, K Brochard, F Corona, F Dressler… - The Lancet, 2016 - thelancet.com
Background Most data for treatment of dermatomyositis and juvenile dermatomyositis are
from anecdotal, non-randomised case series. We aimed to compare, in a randomised trial, the …